Michigan

Overview

Michigan operates the most established medical-and-recreational cannabis framework in the Midwest. The Michigan Medical Marihuana Act (MMMA) (passed as Proposal 1 of 2008 with 63% voter approval) was one of the first comprehensive medical-cannabis programs in the country. A decade later, the Michigan Regulation and Taxation of Marihuana Act (MRTMA) (Proposal 1 of 2018) legalized adult-use cannabis statewide.

Both programs are administered by the Cannabis Regulatory Agency (CRA). Michigan's adult-use market is the largest by sales volume in the Midwest, fueled in part by patients and consumers crossing in from Ohio (until 2024), Indiana, Wisconsin, and Illinois.

Adult-use (MRTMA, 2018)

• Public possession: 2.5 oz flower; 15 g concentrate.
• In-residence: up to 10 oz at home (among the highest in-home limits in the United States).
• Home cultivation: up to 12 plants per household (combined across all resident adults).
• Tax: 10% excise on adult-use sales. FY2021 collected ~$175 million distributed to municipalities by retail-license count.

Medical program (MMMA, 2008)

Qualifying conditions

The MMMA enumerates a list of qualifying conditions that has been expanded periodically by the Marihuana Advisory Panel through CRA rulemaking. Current conditions include cancer, glaucoma, HIV/AIDS, hepatitis C, ALS, Crohn's disease, agitation of Alzheimer's disease, nail patella syndrome, cachexia, severe and chronic pain, severe nausea, seizure disorders (including epilepsy), severe and persistent muscle spasms (including MS), PTSD, autism spectrum disorder, arthritis, rheumatoid arthritis, inflammatory bowel disease, obsessive-compulsive disorder, and others.

Patient access

• Patient possession: 2.5 oz of usable cannabis.
• Patient cultivation: up to 12 plants if the patient (or caregiver on the patient's behalf) elects home cultivation.
• Approved forms: flower, edibles, oils, tinctures, capsules, topicals, vapes (the full spectrum permitted under both medical and adult-use rules).
• Reciprocity: Michigan does not formally recognize out-of-state medical cards for medical-tax preferential pricing; out-of-state patients aged 21+ may purchase from any adult-use retailer.

Patients and caregivers

The MMMA's caregiver framework is the most expansive among legal-rec states and has remained largely intact post-MRTMA.

• Patient minimum age: no statutory floor. Minor patients require a designated caregiver (parent or legal guardian) plus practitioner certification.
• Caregiver minimum age: 21.
• Caregivers per caregiver: a single caregiver may serve up to 5 registered patients (plus self if the caregiver is also a registered patient).
• Caregiver cultivation: up to 12 plants per registered patient the caregiver serves, in addition to the caregiver's own 12 plants if also a patient.
• Caregiver registration: via CRA; criminal background check. Caregivers may not consume the patient's cannabis unless they are also a registered patient.

The caregiver framework is operationally significant: a substantial portion of Michigan's medical-cannabis supply chain historically flowed through licensed caregivers rather than commercial dispensaries.

Patient registration steps

1. Schedule a visit with a Michigan-licensed physician willing to certify a qualifying condition. The certifying physician must establish a bona fide physician-patient relationship.
2. The physician submits a written certification to the Cannabis Regulatory Agency.
3. The patient applies through the CRA Medical Marihuana Registry portal, submits identity documents, proof of Michigan residency, and a current photo. The standard application fee is $40; reduced fees apply for veterans and patients on Medicaid.
4. Approved patients receive a state-issued ID card valid for two years and renewable. The card authorizes purchases at any licensed Michigan dispensary under the medical-program tax preference and the expanded patient cultivation rights.

Minor patients require a designated caregiver (parent or legal guardian) plus practitioner certification. The caregiver completes a separate application and Michigan State Police background check.

Reciprocity and visiting patients

Michigan's framework is dual-track for visitors:

• Adult-use: any visitor 21 or older with a government-issued photo ID may purchase from a licensed adult-use retailer under the 2.5 oz / 15 g cap.
• Medical: Michigan does not formally recognize out-of-state medical cards for medical-program preferential pricing. Visiting medical patients access cannabis through the adult-use retail framework.

The medical-program tax preference is significant for high-volume patients. Visiting medical patients cannot access this preference, the 12-plant cultivation rights, or caregiver designation without Michigan residency.

Caregiver-cultivator framework

Michigan's caregiver framework was structured before adult-use legalization and remained substantively intact under MRTMA. Caregiver-cultivation operations have been the subject of significant legislative and rulemaking debate since 2018:

• The original MMMA permitted broad caregiver-cultivator activity with limited oversight.
• Post-MRTMA proposals have sought to tighten caregiver registration, plant-count audits, and product diversion enforcement.
• The 2024 session considered consolidating caregiver cultivation into the licensed-cultivator framework. The proposal did not advance to enactment.
• Caregivers continue to operate under the original MMMA framework with periodic regulatory clarifications.

The caregiver framework remains operationally significant for patient access in rural and underserved Michigan regions where commercial dispensaries are sparse.

Employment and workplace

Michigan is an at-will employment state. Both the MMMA and MRTMA preserve broad employer discretion:

• Safety-sensitive positions: employers may continue to enforce drug-free workplace policies for safety-sensitive roles as defined by the employer.
• Federal contractor and DOT-regulated positions: federal drug-free workplace and DOT testing rules supersede state-level protection.
• Medical patient discrimination: MMMA provides limited statutory protection against discrimination based on medical patient status alone, but courts have construed the protection narrowly.
• Adult-use: MRTMA does not create a broad off-duty use protection.
• Workers' compensation: post-incident testing positive for THC may affect benefits if impairment is established.

Public-employee positions, healthcare licensing, and CDL holders face additional licensing-board exposure beyond employer discipline.

Hemp-derived intoxicants

Michigan placed hemp-derived intoxicating cannabinoids under CRA regulatory authority through 2022 legislation. Delta-8 THC, delta-9 THC from hemp, delta-10 THC, THC-O, HHC, and similar compounds are restricted to retail channels licensed under the cannabis framework. Hemp-derived products exceeding defined THC thresholds are not lawful for retail sale outside the licensed cannabis supply chain.

Market scale

Michigan operates one of the largest licensed cannabis markets in the United States. Adult-use sales exceeded $3 billion annually by 2024, driven by:

• Strong in-state demand and high in-home possession cap.
• Substantial out-of-state purchasing from Ohio (until 2024 adult-use launch), Indiana, Wisconsin, Illinois, and visitors from Canada.
• Aggressive municipal opt-in: many smaller Michigan municipalities opted in to dispensary licensing for the tax-revenue share.
• Competitive pricing relative to neighboring states.

The market scale has produced significant wholesale price compression and consolidation pressure on smaller operators.

Recent legislative and regulatory history

Notable developments:

• 2008: MMMA (Proposal 1) approved.
• 2018: MRTMA (Proposal 1) approved.
• 2019: licensed adult-use retail sales began December 1.
• 2020-2022: rapid market growth; Cannabis Regulatory Agency consolidated multiple prior regulatory bodies.
• 2023-2024: Issue 1 amendments considered; on-premises consumption framework rolled out in some municipalities.
• 2025-2026: continued legislative work on caregiver-cultivator integration, social-equity license expansion, and licensing-cap balance.

The April 2026 federal Schedule III rescheduling order produced no immediate Michigan legislative response.

Tribal jurisdiction

Michigan includes 12 federally recognized tribal nations. Several nations have established tribal cannabis operations under tribal-state compacts. The Pokagon Band of Potawatomi Indians, Lac Vieux Desert Band of Lake Superior Chippewa, Bay Mills Indian Community, and other tribes have engaged in tribal cannabis governance or operations. Tribal jurisdiction is distinct from state jurisdiction; cannabis transported off tribal land onto state or federal land is subject to applicable non-tribal law.

Federal context

Federal jurisdiction layers additional exposure on federal land, federal courthouses, military installations (Selfridge Air National Guard Base, Wurtsmith Air Force Base (decommissioned), various Coast Guard installations), and interstate highways. Isle Royale National Park, Sleeping Bear Dunes National Lakeshore, Pictured Rocks National Lakeshore, and the substantial federal National Forest footprint (Hiawatha, Huron-Manistee, and Ottawa National Forests) fall under federal jurisdiction where cannabis prohibition applies. I-69, I-75, I-94, I-96, and US-2 corridors see active state-patrol and federal drug-interdiction activity. The Canadian border at Detroit-Windsor and Sault Ste. Marie sees substantial US Customs and Border Protection cannabis-enforcement activity.